Individual holder
LENNON VANDA A
US·3 granted patents·2 pending applications·11 citations·filing 2008–2012
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
5 records- 0184US9891219B2Methods for treating neuromyelitis optica (NMO) by administration of eculizumab to an individual that is aquaporin-4 (AQP4)-IgG autoantibody positiveLENNON VANDA A·Filed 2009·Granted Feb 13, 2018·8 cites·6 claims
- 0278US8524508B2Methods of treating neuromyelitis optica (NMO)LENNON VANDA A·Filed 2008·Granted Sep 3, 2013·3 cites·11 claims
- 0355US2012219969A1Marker for neuromyelitis opticaLENNON VANDA A·Filed 2012·Application pending·0 cites
- 0448US8889102B2Neuromyelitis optica autoantibodies as a marker for neoplasiaLENNON VANDA A·Filed 2008·Granted Nov 18, 2014·0 cites·5 claims
- 0536US2014315225A1Methods and compositions for detecting the presence of one or more autoantibodiesLENNON VANDA A·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LENNON VANDA A files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →